NemaLife Walks to End Alzheimer's Disease
NemaLife Walks to End Alzheimer's Disease
top of page
- Oct 4, 2022
NemaLife joins the International Probiotics Association to create new industry standard
NemaLife is a techbio company focused on high throughput in vivo screening, is delighted to announce that it has joined the International...
- Sep 27, 2022
NemaLife receives funding to develop a neurotherapeutic discovery platform
NemaLife receives funding to develop a neurotherapeutic discovery platform using next-generation psychedelic compounds. LUBBOCK, TX, USA,...
- Sep 13, 2022
NemaLife CTO receives the prestigious REDI award from the National Institute on Aging
NemaLife’s AI-assisted microfluidics-based tech platform receives funding to pursue rapid discovery of drug candidates that could improve...
- May 4, 2022
Motif FoodWorks Announces Strategic Investment in NemaLife, Inc.
The collaboration will support Motif's rapid food-technology product pipeline by utilizing in vivo testing for functional properties of...
- Apr 19, 2022
DEA registered NemaLife Inc. to work with Schedule 1 substances
NemaLife Inc., completed its DEA schedule 1 registration. If you have scheduled compounds (schedule 1-5) to test, reach out to our...
- Jul 20, 2021
Innovative Tech Measures Muscle Strength of Worms in Space to Prepare Astronauts for Future Missions
Loss of muscle mass and strength in astronauts remains an issue for space exploration. C. elegans shares common traits with humans and...
- Nov 20, 2020
First research completed on the whole-life toxicity of CBD
Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...
- Mar 26, 2020
Chemical screening to find hidden Longevity gems?
Start-up NemaLife evolves from platform technology to services provider to identify chemicals that have both positive and negative...
bottom of page